nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—SLC22A1—prostate cancer	0.272	1	CbGaD
Cladribine—ABCG2—Cabazitaxel—prostate cancer	0.0472	0.163	CbGbCtD
Cladribine—ABCG2—Estrone—prostate cancer	0.0461	0.159	CbGbCtD
Cladribine—SLC22A2—Estradiol—prostate cancer	0.0359	0.124	CbGbCtD
Cladribine—SLC22A1—Estradiol—prostate cancer	0.0312	0.108	CbGbCtD
Cladribine—ABCG2—Conjugated Estrogens—prostate cancer	0.0302	0.104	CbGbCtD
Cladribine—ABCG2—Mitoxantrone—prostate cancer	0.0274	0.0948	CbGbCtD
Cladribine—ABCG2—Estradiol—prostate cancer	0.0265	0.0915	CbGbCtD
Cladribine—ABCG2—Etoposide—prostate cancer	0.0173	0.0598	CbGbCtD
Cladribine—ABCG2—Docetaxel—prostate cancer	0.0158	0.0547	CbGbCtD
Cladribine—ABCG2—Doxorubicin—prostate cancer	0.0118	0.0408	CbGbCtD
Cladribine—POLE2—prostate gland—prostate cancer	0.00511	0.0592	CbGeAlD
Cladribine—POLE4—renal system—prostate cancer	0.00399	0.0461	CbGeAlD
Cladribine—RRM2B—prostate gland—prostate cancer	0.003	0.0347	CbGeAlD
Cladribine—POLE3—prostate gland—prostate cancer	0.00284	0.0328	CbGeAlD
Cladribine—SLC28A3—prostate gland—prostate cancer	0.00266	0.0307	CbGeAlD
Cladribine—POLE2—bone marrow—prostate cancer	0.00263	0.0305	CbGeAlD
Cladribine—RRM2B—seminal vesicle—prostate cancer	0.00254	0.0294	CbGeAlD
Cladribine—POLE3—seminal vesicle—prostate cancer	0.0024	0.0278	CbGeAlD
Cladribine—POLE2—testis—prostate cancer	0.00225	0.0261	CbGeAlD
Cladribine—PNP—renal system—prostate cancer	0.0022	0.0255	CbGeAlD
Cladribine—POLE—prostate gland—prostate cancer	0.00216	0.0251	CbGeAlD
Cladribine—RRM2B—renal system—prostate cancer	0.00205	0.0237	CbGeAlD
Cladribine—RRM2B—urethra—prostate cancer	0.00201	0.0233	CbGeAlD
Cladribine—POLE3—renal system—prostate cancer	0.00193	0.0224	CbGeAlD
Cladribine—POLE3—urethra—prostate cancer	0.0019	0.022	CbGeAlD
Cladribine—POLA1—prostate gland—prostate cancer	0.00187	0.0216	CbGeAlD
Cladribine—POLE—seminal vesicle—prostate cancer	0.00183	0.0212	CbGeAlD
Cladribine—RRM2—prostate gland—prostate cancer	0.00178	0.0206	CbGeAlD
Cladribine—PNP—bone marrow—prostate cancer	0.00167	0.0193	CbGeAlD
Cladribine—POLE2—lymph node—prostate cancer	0.00163	0.0189	CbGeAlD
Cladribine—POLA1—seminal vesicle—prostate cancer	0.00158	0.0183	CbGeAlD
Cladribine—RRM2B—bone marrow—prostate cancer	0.00155	0.0179	CbGeAlD
Cladribine—RRM1—prostate gland—prostate cancer	0.00148	0.0171	CbGeAlD
Cladribine—POLE3—bone marrow—prostate cancer	0.00146	0.0169	CbGeAlD
Cladribine—POLE—urethra—prostate cancer	0.00145	0.0168	CbGeAlD
Cladribine—SLC28A3—bone marrow—prostate cancer	0.00137	0.0158	CbGeAlD
Cladribine—RRM2B—testis—prostate cancer	0.00132	0.0153	CbGeAlD
Cladribine—RRM1—seminal vesicle—prostate cancer	0.00125	0.0145	CbGeAlD
Cladribine—POLE3—testis—prostate cancer	0.00125	0.0145	CbGeAlD
Cladribine—POLA1—urethra—prostate cancer	0.00125	0.0145	CbGeAlD
Cladribine—RRM2—renal system—prostate cancer	0.00121	0.0141	CbGeAlD
Cladribine—NR5A1—testis—prostate cancer	0.00121	0.014	CbGeAlD
Cladribine—DCK—prostate gland—prostate cancer	0.00115	0.0133	CbGeAlD
Cladribine—POLE—bone marrow—prostate cancer	0.00112	0.0129	CbGeAlD
Cladribine—RRM1—renal system—prostate cancer	0.00101	0.0117	CbGeAlD
Cladribine—RRM1—urethra—prostate cancer	0.000991	0.0115	CbGeAlD
Cladribine—DCK—seminal vesicle—prostate cancer	0.000973	0.0113	CbGeAlD
Cladribine—POLA1—bone marrow—prostate cancer	0.000961	0.0111	CbGeAlD
Cladribine—RRM2B—lymph node—prostate cancer	0.000958	0.0111	CbGeAlD
Cladribine—POLE—testis—prostate cancer	0.000954	0.011	CbGeAlD
Cladribine—SLC22A2—renal system—prostate cancer	0.000946	0.011	CbGeAlD
Cladribine—RRM2—bone marrow—prostate cancer	0.000919	0.0106	CbGeAlD
Cladribine—POLE3—lymph node—prostate cancer	0.000906	0.0105	CbGeAlD
Cladribine—Azacitidine—DNMT1—prostate cancer	0.000825	0.241	CrCbGaD
Cladribine—POLA1—testis—prostate cancer	0.000822	0.00951	CbGeAlD
Cladribine—Decitabine—DNMT1—prostate cancer	0.000805	0.236	CrCbGaD
Cladribine—RRM2—testis—prostate cancer	0.000785	0.00909	CbGeAlD
Cladribine—DCK—urethra—prostate cancer	0.00077	0.00891	CbGeAlD
Cladribine—RRM1—bone marrow—prostate cancer	0.000763	0.00883	CbGeAlD
Cladribine—POLE—lymph node—prostate cancer	0.000691	0.008	CbGeAlD
Cladribine—SLC22A1—renal system—prostate cancer	0.000669	0.00774	CbGeAlD
Cladribine—Floxuridine—TYMS—prostate cancer	0.000657	0.192	CrCbGaD
Cladribine—RRM1—testis—prostate cancer	0.000652	0.00755	CbGeAlD
Cladribine—ABCG2—prostate gland—prostate cancer	0.000642	0.00743	CbGeAlD
Cladribine—POLA1—lymph node—prostate cancer	0.000596	0.00689	CbGeAlD
Cladribine—DCK—bone marrow—prostate cancer	0.000593	0.00686	CbGeAlD
Cladribine—RRM2—lymph node—prostate cancer	0.000569	0.00659	CbGeAlD
Cladribine—PNP—Paclitaxel—Cabazitaxel—prostate cancer	0.000569	0.12	CbGdCrCtD
Cladribine—ABCG2—seminal vesicle—prostate cancer	0.000543	0.00628	CbGeAlD
Cladribine—Trifluridine—TYMS—prostate cancer	0.000522	0.153	CrCbGaD
Cladribine—DCK—testis—prostate cancer	0.000507	0.00586	CbGeAlD
Cladribine—RRM1—lymph node—prostate cancer	0.000473	0.00547	CbGeAlD
Cladribine—ABCG2—urethra—prostate cancer	0.00043	0.00497	CbGeAlD
Cladribine—POLE—Fulvestrant—Estradiol—prostate cancer	0.000425	0.0894	CbGdCrCtD
Cladribine—DCK—lymph node—prostate cancer	0.000367	0.00425	CbGeAlD
Cladribine—ABCG2—bone marrow—prostate cancer	0.000331	0.00383	CbGeAlD
Cladribine—Adenosine monophosphate—PDE4D—prostate cancer	0.000324	0.0949	CrCbGaD
Cladribine—Adenosine monophosphate—SRC—prostate cancer	0.000284	0.083	CrCbGaD
Cladribine—ABCG2—testis—prostate cancer	0.000283	0.00327	CbGeAlD
Cladribine—RRM1—Fulvestrant—Estradiol—prostate cancer	0.000282	0.0594	CbGdCrCtD
Cladribine—PNP—Paclitaxel—Docetaxel—prostate cancer	0.000236	0.0497	CbGdCrCtD
Cladribine—POLE2—Fulvestrant—Estradiol—prostate cancer	0.000223	0.047	CbGdCrCtD
Cladribine—PNP—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.000213	0.0448	CbGdCrCtD
Cladribine—ABCG2—lymph node—prostate cancer	0.000205	0.00237	CbGeAlD
Cladribine—POLE2—Teniposide—Etoposide—prostate cancer	0.000197	0.0414	CbGdCrCtD
Cladribine—PNP—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.000181	0.0381	CbGdCrCtD
Cladribine—PNP—Fulvestrant—Estradiol—prostate cancer	0.000172	0.0363	CbGdCrCtD
Cladribine—PNP—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.000162	0.034	CbGdCrCtD
Cladribine—PNP—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.000158	0.0332	CbGdCrCtD
Cladribine—DCK—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.000124	0.0262	CbGdCrCtD
Cladribine—POLE2—Doxorubicin—Epirubicin—prostate cancer	0.000103	0.0216	CbGdCrCtD
Cladribine—POLE2—Daunorubicin—Epirubicin—prostate cancer	0.000103	0.0216	CbGdCrCtD
Cladribine—POLE2—Idarubicin—Epirubicin—prostate cancer	0.000103	0.0216	CbGdCrCtD
Cladribine—DCK—Fulvestrant—Estradiol—prostate cancer	0.000101	0.0212	CbGdCrCtD
Cladribine—POLA1—Norethindrone—Ethinyl Estradiol—prostate cancer	9.6e-05	0.0202	CbGdCrCtD
Cladribine—POLE2—Daunorubicin—Doxorubicin—prostate cancer	9.49e-05	0.02	CbGdCrCtD
Cladribine—POLE2—Epirubicin—Doxorubicin—prostate cancer	9.49e-05	0.02	CbGdCrCtD
Cladribine—POLE2—Idarubicin—Doxorubicin—prostate cancer	9.49e-05	0.02	CbGdCrCtD
Cladribine—DCK—Estradiol valerate/Dienogest—Estradiol—prostate cancer	9.43e-05	0.0198	CbGdCrCtD
Cladribine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	9.21e-05	0.0194	CbGdCrCtD
Cladribine—DCK—Levorphanol—Estrone—prostate cancer	8.78e-05	0.0185	CbGdCrCtD
Cladribine—PNP—Daunorubicin—Epirubicin—prostate cancer	7.91e-05	0.0166	CbGdCrCtD
Cladribine—POLA1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	7.64e-05	0.0161	CbGdCrCtD
Cladribine—PNP—Danazol—Ethinyl Estradiol—prostate cancer	7.52e-05	0.0158	CbGdCrCtD
Cladribine—PNP—Daunorubicin—Doxorubicin—prostate cancer	7.32e-05	0.0154	CbGdCrCtD
Cladribine—PNP—Norethindrone—Ethinyl Estradiol—prostate cancer	6.78e-05	0.0143	CbGdCrCtD
Cladribine—DCK—Levorphanol—Estradiol—prostate cancer	6.65e-05	0.014	CbGdCrCtD
Cladribine—PNP—Levonorgestrel—Ethinyl Estradiol—prostate cancer	5.39e-05	0.0113	CbGdCrCtD
Cladribine—DCK—Doxorubicin—Epirubicin—prostate cancer	4.62e-05	0.00972	CbGdCrCtD
Cladribine—DCK—Epirubicin—Doxorubicin—prostate cancer	4.28e-05	0.009	CbGdCrCtD
Cladribine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	4.25e-05	0.000203	CcSEcCtD
Cladribine—Oedema—Capecitabine—prostate cancer	4.24e-05	0.000203	CcSEcCtD
Cladribine—Renal failure—Doxorubicin—prostate cancer	4.22e-05	0.000201	CcSEcCtD
Cladribine—Infection—Capecitabine—prostate cancer	4.22e-05	0.000201	CcSEcCtD
Cladribine—Urticaria—Etoposide—prostate cancer	4.19e-05	0.0002	CcSEcCtD
Cladribine—Haemoglobin—Epirubicin—prostate cancer	4.18e-05	0.0002	CcSEcCtD
Cladribine—Anorexia—Docetaxel—prostate cancer	4.18e-05	0.0002	CcSEcCtD
Cladribine—Malaise—Prednisone—prostate cancer	4.18e-05	0.0002	CcSEcCtD
Cladribine—Body temperature increased—Etoposide—prostate cancer	4.17e-05	0.000199	CcSEcCtD
Cladribine—Abdominal pain—Etoposide—prostate cancer	4.17e-05	0.000199	CcSEcCtD
Cladribine—Conjunctivitis—Doxorubicin—prostate cancer	4.17e-05	0.000199	CcSEcCtD
Cladribine—Urinary tract infection—Doxorubicin—prostate cancer	4.17e-05	0.000199	CcSEcCtD
Cladribine—Nervous system disorder—Capecitabine—prostate cancer	4.16e-05	0.000199	CcSEcCtD
Cladribine—Haemorrhage—Epirubicin—prostate cancer	4.16e-05	0.000199	CcSEcCtD
Cladribine—Thrombocytopenia—Capecitabine—prostate cancer	4.15e-05	0.000198	CcSEcCtD
Cladribine—Tachycardia—Capecitabine—prostate cancer	4.14e-05	0.000198	CcSEcCtD
Cladribine—Pharyngitis—Epirubicin—prostate cancer	4.13e-05	0.000197	CcSEcCtD
Cladribine—Skin disorder—Capecitabine—prostate cancer	4.12e-05	0.000197	CcSEcCtD
Cladribine—Urinary tract disorder—Epirubicin—prostate cancer	4.11e-05	0.000196	CcSEcCtD
Cladribine—Hyperhidrosis—Capecitabine—prostate cancer	4.1e-05	0.000196	CcSEcCtD
Cladribine—Oedema peripheral—Epirubicin—prostate cancer	4.1e-05	0.000196	CcSEcCtD
Cladribine—Hypotension—Docetaxel—prostate cancer	4.1e-05	0.000196	CcSEcCtD
Cladribine—Connective tissue disorder—Epirubicin—prostate cancer	4.09e-05	0.000195	CcSEcCtD
Cladribine—Urethral disorder—Epirubicin—prostate cancer	4.08e-05	0.000195	CcSEcCtD
Cladribine—Hepatobiliary disease—Doxorubicin—prostate cancer	4.06e-05	0.000194	CcSEcCtD
Cladribine—Epistaxis—Doxorubicin—prostate cancer	4.05e-05	0.000193	CcSEcCtD
Cladribine—Anorexia—Capecitabine—prostate cancer	4.04e-05	0.000193	CcSEcCtD
Cladribine—Nausea—Estradiol—prostate cancer	4.04e-05	0.000193	CcSEcCtD
Cladribine—Vomiting—Mitoxantrone—prostate cancer	4.03e-05	0.000193	CcSEcCtD
Cladribine—Rash—Mitoxantrone—prostate cancer	4e-05	0.000191	CcSEcCtD
Cladribine—Dermatitis—Mitoxantrone—prostate cancer	3.99e-05	0.000191	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.99e-05	0.000191	CcSEcCtD
Cladribine—Headache—Mitoxantrone—prostate cancer	3.97e-05	0.00019	CcSEcCtD
Cladribine—Hypotension—Capecitabine—prostate cancer	3.97e-05	0.000189	CcSEcCtD
Cladribine—Insomnia—Docetaxel—prostate cancer	3.96e-05	0.000189	CcSEcCtD
Cladribine—Arthralgia—Prednisone—prostate cancer	3.94e-05	0.000188	CcSEcCtD
Cladribine—Myalgia—Prednisone—prostate cancer	3.94e-05	0.000188	CcSEcCtD
Cladribine—Paraesthesia—Docetaxel—prostate cancer	3.94e-05	0.000188	CcSEcCtD
Cladribine—Erythema multiforme—Epirubicin—prostate cancer	3.93e-05	0.000188	CcSEcCtD
Cladribine—Anxiety—Prednisone—prostate cancer	3.93e-05	0.000188	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.92e-05	0.000187	CcSEcCtD
Cladribine—Dyspnoea—Docetaxel—prostate cancer	3.91e-05	0.000187	CcSEcCtD
Cladribine—Somnolence—Docetaxel—prostate cancer	3.9e-05	0.000186	CcSEcCtD
Cladribine—Discomfort—Prednisone—prostate cancer	3.9e-05	0.000186	CcSEcCtD
Cladribine—Eye disorder—Epirubicin—prostate cancer	3.89e-05	0.000186	CcSEcCtD
Cladribine—Hypersensitivity—Etoposide—prostate cancer	3.89e-05	0.000186	CcSEcCtD
Cladribine—Haemoglobin—Doxorubicin—prostate cancer	3.87e-05	0.000185	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.87e-05	0.000185	CcSEcCtD
Cladribine—Cardiac disorder—Epirubicin—prostate cancer	3.86e-05	0.000184	CcSEcCtD
Cladribine—Haemorrhage—Doxorubicin—prostate cancer	3.85e-05	0.000184	CcSEcCtD
Cladribine—Insomnia—Capecitabine—prostate cancer	3.84e-05	0.000183	CcSEcCtD
Cladribine—Pharyngitis—Doxorubicin—prostate cancer	3.82e-05	0.000183	CcSEcCtD
Cladribine—Paraesthesia—Capecitabine—prostate cancer	3.81e-05	0.000182	CcSEcCtD
Cladribine—Decreased appetite—Docetaxel—prostate cancer	3.81e-05	0.000182	CcSEcCtD
Cladribine—Urinary tract disorder—Doxorubicin—prostate cancer	3.8e-05	0.000182	CcSEcCtD
Cladribine—Oedema peripheral—Doxorubicin—prostate cancer	3.79e-05	0.000181	CcSEcCtD
Cladribine—Gastrointestinal disorder—Docetaxel—prostate cancer	3.78e-05	0.000181	CcSEcCtD
Cladribine—Asthenia—Etoposide—prostate cancer	3.78e-05	0.000181	CcSEcCtD
Cladribine—Connective tissue disorder—Doxorubicin—prostate cancer	3.78e-05	0.000181	CcSEcCtD
Cladribine—Dyspnoea—Capecitabine—prostate cancer	3.78e-05	0.000181	CcSEcCtD
Cladribine—Oedema—Prednisone—prostate cancer	3.78e-05	0.000181	CcSEcCtD
Cladribine—Fatigue—Docetaxel—prostate cancer	3.78e-05	0.000181	CcSEcCtD
Cladribine—Angiopathy—Epirubicin—prostate cancer	3.78e-05	0.00018	CcSEcCtD
Cladribine—Urethral disorder—Doxorubicin—prostate cancer	3.77e-05	0.00018	CcSEcCtD
Cladribine—Nausea—Mitoxantrone—prostate cancer	3.77e-05	0.00018	CcSEcCtD
Cladribine—Immune system disorder—Epirubicin—prostate cancer	3.76e-05	0.00018	CcSEcCtD
Cladribine—Infection—Prednisone—prostate cancer	3.76e-05	0.000179	CcSEcCtD
Cladribine—Mediastinal disorder—Epirubicin—prostate cancer	3.75e-05	0.000179	CcSEcCtD
Cladribine—Constipation—Docetaxel—prostate cancer	3.75e-05	0.000179	CcSEcCtD
Cladribine—Pain—Docetaxel—prostate cancer	3.75e-05	0.000179	CcSEcCtD
Cladribine—Chills—Epirubicin—prostate cancer	3.73e-05	0.000178	CcSEcCtD
Cladribine—Pruritus—Etoposide—prostate cancer	3.73e-05	0.000178	CcSEcCtD
Cladribine—Arrhythmia—Epirubicin—prostate cancer	3.72e-05	0.000178	CcSEcCtD
Cladribine—Nervous system disorder—Prednisone—prostate cancer	3.71e-05	0.000177	CcSEcCtD
Cladribine—Tachycardia—Prednisone—prostate cancer	3.69e-05	0.000176	CcSEcCtD
Cladribine—Decreased appetite—Capecitabine—prostate cancer	3.69e-05	0.000176	CcSEcCtD
Cladribine—Alopecia—Epirubicin—prostate cancer	3.68e-05	0.000176	CcSEcCtD
Cladribine—Skin disorder—Prednisone—prostate cancer	3.67e-05	0.000175	CcSEcCtD
Cladribine—Gastrointestinal disorder—Capecitabine—prostate cancer	3.66e-05	0.000175	CcSEcCtD
Cladribine—Fatigue—Capecitabine—prostate cancer	3.66e-05	0.000175	CcSEcCtD
Cladribine—Hyperhidrosis—Prednisone—prostate cancer	3.65e-05	0.000175	CcSEcCtD
Cladribine—Mental disorder—Epirubicin—prostate cancer	3.65e-05	0.000174	CcSEcCtD
Cladribine—Erythema multiforme—Doxorubicin—prostate cancer	3.64e-05	0.000174	CcSEcCtD
Cladribine—Pain—Capecitabine—prostate cancer	3.63e-05	0.000173	CcSEcCtD
Cladribine—Constipation—Capecitabine—prostate cancer	3.63e-05	0.000173	CcSEcCtD
Cladribine—Erythema—Epirubicin—prostate cancer	3.62e-05	0.000173	CcSEcCtD
Cladribine—Malnutrition—Epirubicin—prostate cancer	3.62e-05	0.000173	CcSEcCtD
Cladribine—Feeling abnormal—Docetaxel—prostate cancer	3.61e-05	0.000173	CcSEcCtD
Cladribine—Diarrhoea—Etoposide—prostate cancer	3.61e-05	0.000172	CcSEcCtD
Cladribine—Anorexia—Prednisone—prostate cancer	3.6e-05	0.000172	CcSEcCtD
Cladribine—Eye disorder—Doxorubicin—prostate cancer	3.6e-05	0.000172	CcSEcCtD
Cladribine—Gastrointestinal pain—Docetaxel—prostate cancer	3.58e-05	0.000171	CcSEcCtD
Cladribine—Cardiac disorder—Doxorubicin—prostate cancer	3.57e-05	0.000171	CcSEcCtD
Cladribine—Flatulence—Epirubicin—prostate cancer	3.57e-05	0.00017	CcSEcCtD
Cladribine—Back pain—Epirubicin—prostate cancer	3.5e-05	0.000167	CcSEcCtD
Cladribine—Feeling abnormal—Capecitabine—prostate cancer	3.5e-05	0.000167	CcSEcCtD
Cladribine—PNP—Clobetasol propionate—Prednisone—prostate cancer	3.49e-05	0.00735	CbGdCrCtD
Cladribine—Angiopathy—Doxorubicin—prostate cancer	3.49e-05	0.000167	CcSEcCtD
Cladribine—Dizziness—Etoposide—prostate cancer	3.49e-05	0.000167	CcSEcCtD
Cladribine—Immune system disorder—Doxorubicin—prostate cancer	3.48e-05	0.000166	CcSEcCtD
Cladribine—Gastrointestinal pain—Capecitabine—prostate cancer	3.47e-05	0.000166	CcSEcCtD
Cladribine—Mediastinal disorder—Doxorubicin—prostate cancer	3.47e-05	0.000166	CcSEcCtD
Cladribine—Abdominal pain—Docetaxel—prostate cancer	3.46e-05	0.000166	CcSEcCtD
Cladribine—Body temperature increased—Docetaxel—prostate cancer	3.46e-05	0.000166	CcSEcCtD
Cladribine—Chills—Doxorubicin—prostate cancer	3.45e-05	0.000165	CcSEcCtD
Cladribine—PNP—Flunisolide—Prednisone—prostate cancer	3.45e-05	0.00725	CbGdCrCtD
Cladribine—Musculoskeletal discomfort—Prednisone—prostate cancer	3.44e-05	0.000164	CcSEcCtD
Cladribine—Arrhythmia—Doxorubicin—prostate cancer	3.44e-05	0.000164	CcSEcCtD
Cladribine—Insomnia—Prednisone—prostate cancer	3.42e-05	0.000163	CcSEcCtD
Cladribine—Alopecia—Doxorubicin—prostate cancer	3.4e-05	0.000163	CcSEcCtD
Cladribine—Paraesthesia—Prednisone—prostate cancer	3.39e-05	0.000162	CcSEcCtD
Cladribine—Mental disorder—Doxorubicin—prostate cancer	3.37e-05	0.000161	CcSEcCtD
Cladribine—Urticaria—Capecitabine—prostate cancer	3.37e-05	0.000161	CcSEcCtD
Cladribine—Ill-defined disorder—Epirubicin—prostate cancer	3.36e-05	0.000161	CcSEcCtD
Cladribine—Abdominal pain—Capecitabine—prostate cancer	3.35e-05	0.00016	CcSEcCtD
Cladribine—Body temperature increased—Capecitabine—prostate cancer	3.35e-05	0.00016	CcSEcCtD
Cladribine—Vomiting—Etoposide—prostate cancer	3.35e-05	0.00016	CcSEcCtD
Cladribine—Erythema—Doxorubicin—prostate cancer	3.35e-05	0.00016	CcSEcCtD
Cladribine—Malnutrition—Doxorubicin—prostate cancer	3.35e-05	0.00016	CcSEcCtD
Cladribine—Anaemia—Epirubicin—prostate cancer	3.35e-05	0.00016	CcSEcCtD
Cladribine—Rash—Etoposide—prostate cancer	3.33e-05	0.000159	CcSEcCtD
Cladribine—Dermatitis—Etoposide—prostate cancer	3.32e-05	0.000159	CcSEcCtD
Cladribine—Headache—Etoposide—prostate cancer	3.3e-05	0.000158	CcSEcCtD
Cladribine—Flatulence—Doxorubicin—prostate cancer	3.3e-05	0.000158	CcSEcCtD
Cladribine—Decreased appetite—Prednisone—prostate cancer	3.29e-05	0.000157	CcSEcCtD
Cladribine—Malaise—Epirubicin—prostate cancer	3.27e-05	0.000156	CcSEcCtD
Cladribine—Fatigue—Prednisone—prostate cancer	3.26e-05	0.000156	CcSEcCtD
Cladribine—Back pain—Doxorubicin—prostate cancer	3.24e-05	0.000155	CcSEcCtD
Cladribine—Constipation—Prednisone—prostate cancer	3.23e-05	0.000154	CcSEcCtD
Cladribine—Hypersensitivity—Docetaxel—prostate cancer	3.23e-05	0.000154	CcSEcCtD
Cladribine—Cough—Epirubicin—prostate cancer	3.16e-05	0.000151	CcSEcCtD
Cladribine—DCK—Levonorgestrel—Ethinyl Estradiol—prostate cancer	3.15e-05	0.00663	CbGdCrCtD
Cladribine—Asthenia—Docetaxel—prostate cancer	3.14e-05	0.00015	CcSEcCtD
Cladribine—Nausea—Etoposide—prostate cancer	3.13e-05	0.00015	CcSEcCtD
Cladribine—Hypersensitivity—Capecitabine—prostate cancer	3.13e-05	0.000149	CcSEcCtD
Cladribine—Feeling abnormal—Prednisone—prostate cancer	3.11e-05	0.000149	CcSEcCtD
Cladribine—Ill-defined disorder—Doxorubicin—prostate cancer	3.11e-05	0.000149	CcSEcCtD
Cladribine—Pruritus—Docetaxel—prostate cancer	3.1e-05	0.000148	CcSEcCtD
Cladribine—Anaemia—Doxorubicin—prostate cancer	3.1e-05	0.000148	CcSEcCtD
Cladribine—Gastrointestinal pain—Prednisone—prostate cancer	3.09e-05	0.000148	CcSEcCtD
Cladribine—Arthralgia—Epirubicin—prostate cancer	3.08e-05	0.000147	CcSEcCtD
Cladribine—Chest pain—Epirubicin—prostate cancer	3.08e-05	0.000147	CcSEcCtD
Cladribine—Myalgia—Epirubicin—prostate cancer	3.08e-05	0.000147	CcSEcCtD
Cladribine—Anxiety—Epirubicin—prostate cancer	3.07e-05	0.000147	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.06e-05	0.000146	CcSEcCtD
Cladribine—Discomfort—Epirubicin—prostate cancer	3.05e-05	0.000146	CcSEcCtD
Cladribine—Asthenia—Capecitabine—prostate cancer	3.04e-05	0.000145	CcSEcCtD
Cladribine—Malaise—Doxorubicin—prostate cancer	3.02e-05	0.000144	CcSEcCtD
Cladribine—Urticaria—Prednisone—prostate cancer	3e-05	0.000143	CcSEcCtD
Cladribine—Pruritus—Capecitabine—prostate cancer	3e-05	0.000143	CcSEcCtD
Cladribine—Diarrhoea—Docetaxel—prostate cancer	3e-05	0.000143	CcSEcCtD
Cladribine—Abdominal pain—Prednisone—prostate cancer	2.99e-05	0.000143	CcSEcCtD
Cladribine—Body temperature increased—Prednisone—prostate cancer	2.99e-05	0.000143	CcSEcCtD
Cladribine—Confusional state—Epirubicin—prostate cancer	2.98e-05	0.000142	CcSEcCtD
Cladribine—Oedema—Epirubicin—prostate cancer	2.96e-05	0.000141	CcSEcCtD
Cladribine—Infection—Epirubicin—prostate cancer	2.94e-05	0.00014	CcSEcCtD
Cladribine—Cough—Doxorubicin—prostate cancer	2.92e-05	0.00014	CcSEcCtD
Cladribine—Diarrhoea—Capecitabine—prostate cancer	2.9e-05	0.000139	CcSEcCtD
Cladribine—Nervous system disorder—Epirubicin—prostate cancer	2.9e-05	0.000138	CcSEcCtD
Cladribine—Dizziness—Docetaxel—prostate cancer	2.9e-05	0.000138	CcSEcCtD
Cladribine—Thrombocytopenia—Epirubicin—prostate cancer	2.89e-05	0.000138	CcSEcCtD
Cladribine—Tachycardia—Epirubicin—prostate cancer	2.89e-05	0.000138	CcSEcCtD
Cladribine—Skin disorder—Epirubicin—prostate cancer	2.87e-05	0.000137	CcSEcCtD
Cladribine—Hyperhidrosis—Epirubicin—prostate cancer	2.86e-05	0.000137	CcSEcCtD
Cladribine—Chest pain—Doxorubicin—prostate cancer	2.85e-05	0.000136	CcSEcCtD
Cladribine—Arthralgia—Doxorubicin—prostate cancer	2.85e-05	0.000136	CcSEcCtD
Cladribine—Myalgia—Doxorubicin—prostate cancer	2.85e-05	0.000136	CcSEcCtD
Cladribine—Anxiety—Doxorubicin—prostate cancer	2.84e-05	0.000136	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.83e-05	0.000135	CcSEcCtD
Cladribine—Discomfort—Doxorubicin—prostate cancer	2.82e-05	0.000135	CcSEcCtD
Cladribine—Anorexia—Epirubicin—prostate cancer	2.82e-05	0.000135	CcSEcCtD
Cladribine—Dizziness—Capecitabine—prostate cancer	2.81e-05	0.000134	CcSEcCtD
Cladribine—Vomiting—Docetaxel—prostate cancer	2.79e-05	0.000133	CcSEcCtD
Cladribine—Hypersensitivity—Prednisone—prostate cancer	2.78e-05	0.000133	CcSEcCtD
Cladribine—Rash—Docetaxel—prostate cancer	2.76e-05	0.000132	CcSEcCtD
Cladribine—Hypotension—Epirubicin—prostate cancer	2.76e-05	0.000132	CcSEcCtD
Cladribine—Dermatitis—Docetaxel—prostate cancer	2.76e-05	0.000132	CcSEcCtD
Cladribine—Confusional state—Doxorubicin—prostate cancer	2.76e-05	0.000132	CcSEcCtD
Cladribine—Headache—Docetaxel—prostate cancer	2.75e-05	0.000131	CcSEcCtD
Cladribine—Oedema—Doxorubicin—prostate cancer	2.74e-05	0.000131	CcSEcCtD
Cladribine—Infection—Doxorubicin—prostate cancer	2.72e-05	0.00013	CcSEcCtD
Cladribine—Asthenia—Prednisone—prostate cancer	2.71e-05	0.00013	CcSEcCtD
Cladribine—Vomiting—Capecitabine—prostate cancer	2.7e-05	0.000129	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.69e-05	0.000129	CcSEcCtD
Cladribine—Nervous system disorder—Doxorubicin—prostate cancer	2.68e-05	0.000128	CcSEcCtD
Cladribine—Thrombocytopenia—Doxorubicin—prostate cancer	2.68e-05	0.000128	CcSEcCtD
Cladribine—Rash—Capecitabine—prostate cancer	2.68e-05	0.000128	CcSEcCtD
Cladribine—Pruritus—Prednisone—prostate cancer	2.67e-05	0.000128	CcSEcCtD
Cladribine—Insomnia—Epirubicin—prostate cancer	2.67e-05	0.000128	CcSEcCtD
Cladribine—Dermatitis—Capecitabine—prostate cancer	2.67e-05	0.000128	CcSEcCtD
Cladribine—Tachycardia—Doxorubicin—prostate cancer	2.67e-05	0.000128	CcSEcCtD
Cladribine—Headache—Capecitabine—prostate cancer	2.66e-05	0.000127	CcSEcCtD
Cladribine—Skin disorder—Doxorubicin—prostate cancer	2.66e-05	0.000127	CcSEcCtD
Cladribine—Paraesthesia—Epirubicin—prostate cancer	2.65e-05	0.000127	CcSEcCtD
Cladribine—Hyperhidrosis—Doxorubicin—prostate cancer	2.64e-05	0.000126	CcSEcCtD
Cladribine—PNP—Danazol—Prednisone—prostate cancer	2.64e-05	0.00556	CbGdCrCtD
Cladribine—Dyspnoea—Epirubicin—prostate cancer	2.64e-05	0.000126	CcSEcCtD
Cladribine—Somnolence—Epirubicin—prostate cancer	2.63e-05	0.000126	CcSEcCtD
Cladribine—Anorexia—Doxorubicin—prostate cancer	2.61e-05	0.000125	CcSEcCtD
Cladribine—Nausea—Docetaxel—prostate cancer	2.6e-05	0.000124	CcSEcCtD
Cladribine—Diarrhoea—Prednisone—prostate cancer	2.59e-05	0.000124	CcSEcCtD
Cladribine—Decreased appetite—Epirubicin—prostate cancer	2.57e-05	0.000123	CcSEcCtD
Cladribine—Hypotension—Doxorubicin—prostate cancer	2.56e-05	0.000122	CcSEcCtD
Cladribine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.55e-05	0.000122	CcSEcCtD
Cladribine—Fatigue—Epirubicin—prostate cancer	2.55e-05	0.000122	CcSEcCtD
Cladribine—Pain—Epirubicin—prostate cancer	2.53e-05	0.000121	CcSEcCtD
Cladribine—Constipation—Epirubicin—prostate cancer	2.53e-05	0.000121	CcSEcCtD
Cladribine—Nausea—Capecitabine—prostate cancer	2.52e-05	0.00012	CcSEcCtD
Cladribine—Dizziness—Prednisone—prostate cancer	2.5e-05	0.000119	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.49e-05	0.000119	CcSEcCtD
Cladribine—Insomnia—Doxorubicin—prostate cancer	2.47e-05	0.000118	CcSEcCtD
Cladribine—Paraesthesia—Doxorubicin—prostate cancer	2.46e-05	0.000117	CcSEcCtD
Cladribine—Dyspnoea—Doxorubicin—prostate cancer	2.44e-05	0.000116	CcSEcCtD
Cladribine—Feeling abnormal—Epirubicin—prostate cancer	2.44e-05	0.000116	CcSEcCtD
Cladribine—Somnolence—Doxorubicin—prostate cancer	2.43e-05	0.000116	CcSEcCtD
Cladribine—Gastrointestinal pain—Epirubicin—prostate cancer	2.42e-05	0.000115	CcSEcCtD
Cladribine—Vomiting—Prednisone—prostate cancer	2.4e-05	0.000115	CcSEcCtD
Cladribine—Rash—Prednisone—prostate cancer	2.38e-05	0.000114	CcSEcCtD
Cladribine—Dermatitis—Prednisone—prostate cancer	2.38e-05	0.000114	CcSEcCtD
Cladribine—Decreased appetite—Doxorubicin—prostate cancer	2.38e-05	0.000114	CcSEcCtD
Cladribine—Headache—Prednisone—prostate cancer	2.37e-05	0.000113	CcSEcCtD
Cladribine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.36e-05	0.000113	CcSEcCtD
Cladribine—Fatigue—Doxorubicin—prostate cancer	2.36e-05	0.000113	CcSEcCtD
Cladribine—Urticaria—Epirubicin—prostate cancer	2.35e-05	0.000112	CcSEcCtD
Cladribine—Pain—Doxorubicin—prostate cancer	2.34e-05	0.000112	CcSEcCtD
Cladribine—Constipation—Doxorubicin—prostate cancer	2.34e-05	0.000112	CcSEcCtD
Cladribine—Abdominal pain—Epirubicin—prostate cancer	2.34e-05	0.000112	CcSEcCtD
Cladribine—Body temperature increased—Epirubicin—prostate cancer	2.34e-05	0.000112	CcSEcCtD
Cladribine—Feeling abnormal—Doxorubicin—prostate cancer	2.25e-05	0.000108	CcSEcCtD
Cladribine—Nausea—Prednisone—prostate cancer	2.25e-05	0.000107	CcSEcCtD
Cladribine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.24e-05	0.000107	CcSEcCtD
Cladribine—Hypersensitivity—Epirubicin—prostate cancer	2.18e-05	0.000104	CcSEcCtD
Cladribine—Urticaria—Doxorubicin—prostate cancer	2.17e-05	0.000104	CcSEcCtD
Cladribine—Abdominal pain—Doxorubicin—prostate cancer	2.16e-05	0.000103	CcSEcCtD
Cladribine—Body temperature increased—Doxorubicin—prostate cancer	2.16e-05	0.000103	CcSEcCtD
Cladribine—Asthenia—Epirubicin—prostate cancer	2.12e-05	0.000101	CcSEcCtD
Cladribine—Pruritus—Epirubicin—prostate cancer	2.09e-05	9.99e-05	CcSEcCtD
Cladribine—Diarrhoea—Epirubicin—prostate cancer	2.02e-05	9.66e-05	CcSEcCtD
Cladribine—Hypersensitivity—Doxorubicin—prostate cancer	2.02e-05	9.63e-05	CcSEcCtD
Cladribine—Asthenia—Doxorubicin—prostate cancer	1.96e-05	9.37e-05	CcSEcCtD
Cladribine—Dizziness—Epirubicin—prostate cancer	1.95e-05	9.34e-05	CcSEcCtD
Cladribine—Pruritus—Doxorubicin—prostate cancer	1.94e-05	9.24e-05	CcSEcCtD
Cladribine—DCK—Desoximetasone—Prednisone—prostate cancer	1.89e-05	0.00398	CbGdCrCtD
Cladribine—Vomiting—Epirubicin—prostate cancer	1.88e-05	8.98e-05	CcSEcCtD
Cladribine—Diarrhoea—Doxorubicin—prostate cancer	1.87e-05	8.94e-05	CcSEcCtD
Cladribine—Rash—Epirubicin—prostate cancer	1.86e-05	8.9e-05	CcSEcCtD
Cladribine—Dermatitis—Epirubicin—prostate cancer	1.86e-05	8.9e-05	CcSEcCtD
Cladribine—Headache—Epirubicin—prostate cancer	1.85e-05	8.85e-05	CcSEcCtD
Cladribine—DCK—Diflorasone—Prednisone—prostate cancer	1.84e-05	0.00386	CbGdCrCtD
Cladribine—Dizziness—Doxorubicin—prostate cancer	1.81e-05	8.64e-05	CcSEcCtD
Cladribine—Nausea—Epirubicin—prostate cancer	1.76e-05	8.39e-05	CcSEcCtD
Cladribine—Vomiting—Doxorubicin—prostate cancer	1.74e-05	8.31e-05	CcSEcCtD
Cladribine—Rash—Doxorubicin—prostate cancer	1.72e-05	8.24e-05	CcSEcCtD
Cladribine—Dermatitis—Doxorubicin—prostate cancer	1.72e-05	8.23e-05	CcSEcCtD
Cladribine—Headache—Doxorubicin—prostate cancer	1.71e-05	8.19e-05	CcSEcCtD
Cladribine—Nausea—Doxorubicin—prostate cancer	1.62e-05	7.76e-05	CcSEcCtD
Cladribine—RRM2—Metabolism—PPARA—prostate cancer	8.93e-06	6.63e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LDHB—prostate cancer	8.92e-06	6.63e-05	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—MDM2—prostate cancer	8.85e-06	6.58e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—INS—prostate cancer	8.79e-06	6.53e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP3A5—prostate cancer	8.76e-06	6.51e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1B—prostate cancer	8.75e-06	6.51e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC22A3—prostate cancer	8.75e-06	6.5e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HSD3B1—prostate cancer	8.75e-06	6.5e-05	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PIK3CA—prostate cancer	8.71e-06	6.47e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HSD3B1—prostate cancer	8.66e-06	6.43e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC22A3—prostate cancer	8.66e-06	6.43e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CREBBP—prostate cancer	8.61e-06	6.4e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—RXRA—prostate cancer	8.61e-06	6.4e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—EP300—prostate cancer	8.6e-06	6.39e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—MTHFR—prostate cancer	8.5e-06	6.32e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MYC—prostate cancer	8.5e-06	6.32e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PDHA1—prostate cancer	8.46e-06	6.29e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—UCP3—prostate cancer	8.46e-06	6.29e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTA3—prostate cancer	8.46e-06	6.29e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TCN2—prostate cancer	8.46e-06	6.29e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CAV1—prostate cancer	8.39e-06	6.24e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TBXAS1—prostate cancer	8.39e-06	6.23e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTA4—prostate cancer	8.39e-06	6.23e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CCND1—prostate cancer	8.35e-06	6.21e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARA—prostate cancer	8.34e-06	6.2e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTA4—prostate cancer	8.3e-06	6.17e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TBXAS1—prostate cancer	8.3e-06	6.17e-05	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—MDM2—prostate cancer	8.25e-06	6.13e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTA2—prostate cancer	8.17e-06	6.07e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CD—prostate cancer	8.16e-06	6.07e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTA2—prostate cancer	8.09e-06	6.01e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1A—prostate cancer	8.08e-06	6e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SULT1A1—prostate cancer	8.07e-06	6e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ABCG5—prostate cancer	8.07e-06	6e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HSD3B1—prostate cancer	8.07e-06	6e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC22A3—prostate cancer	8.07e-06	6e-05	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—prostate cancer	8.04e-06	5.98e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SULT1A1—prostate cancer	7.99e-06	5.94e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ABCG5—prostate cancer	7.99e-06	5.94e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTA1—prostate cancer	7.89e-06	5.86e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—CAV1—prostate cancer	7.84e-06	5.83e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTA1—prostate cancer	7.8e-06	5.8e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NAT2—prostate cancer	7.8e-06	5.79e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HSD3B2—prostate cancer	7.8e-06	5.79e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTO1—prostate cancer	7.8e-06	5.79e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTA4—prostate cancer	7.74e-06	5.75e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TBXAS1—prostate cancer	7.74e-06	5.75e-05	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—prostate cancer	7.72e-06	5.74e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTO1—prostate cancer	7.72e-06	5.73e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NAT2—prostate cancer	7.72e-06	5.73e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HSD3B2—prostate cancer	7.72e-06	5.73e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—NOS3—prostate cancer	7.71e-06	5.73e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—EP300—prostate cancer	7.69e-06	5.71e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CG—prostate cancer	7.65e-06	5.68e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—PIK3CA—prostate cancer	7.55e-06	5.61e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTA2—prostate cancer	7.54e-06	5.6e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MYC—prostate cancer	7.49e-06	5.57e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LRP2—prostate cancer	7.47e-06	5.56e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PLCB2—prostate cancer	7.47e-06	5.56e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2C18—prostate cancer	7.47e-06	5.56e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SULT1A1—prostate cancer	7.45e-06	5.53e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCG5—prostate cancer	7.45e-06	5.53e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PLCB2—prostate cancer	7.4e-06	5.5e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LRP2—prostate cancer	7.4e-06	5.5e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2C18—prostate cancer	7.4e-06	5.5e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—P4HB—prostate cancer	7.33e-06	5.45e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTA1—prostate cancer	7.27e-06	5.41e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—P4HB—prostate cancer	7.25e-06	5.39e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—INS—prostate cancer	7.24e-06	5.38e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NAT2—prostate cancer	7.19e-06	5.34e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HSD3B2—prostate cancer	7.19e-06	5.34e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTO1—prostate cancer	7.19e-06	5.34e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CG—prostate cancer	7.14e-06	5.31e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC22A1—prostate cancer	7.13e-06	5.3e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—PPARA—prostate cancer	7.13e-06	5.3e-05	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKT1—prostate cancer	7.11e-06	5.29e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CB—prostate cancer	7.11e-06	5.29e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CREBBP—prostate cancer	7.09e-06	5.27e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC22A1—prostate cancer	7.06e-06	5.24e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—PPARA—prostate cancer	7.05e-06	5.24e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGS2—prostate cancer	7.05e-06	5.24e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SULT2A1—prostate cancer	6.95e-06	5.16e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PLCB2—prostate cancer	6.9e-06	5.12e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LRP2—prostate cancer	6.9e-06	5.12e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2C18—prostate cancer	6.9e-06	5.12e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SULT2A1—prostate cancer	6.88e-06	5.11e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MED12—prostate cancer	6.84e-06	5.08e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GNG5—prostate cancer	6.78e-06	5.04e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MED12—prostate cancer	6.77e-06	5.03e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—INS—prostate cancer	6.76e-06	5.03e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—P4HB—prostate cancer	6.76e-06	5.03e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CD—prostate cancer	6.72e-06	5e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GNG5—prostate cancer	6.71e-06	4.99e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MYC—prostate cancer	6.7e-06	4.98e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—CREBBP—prostate cancer	6.62e-06	4.92e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—PPARA—prostate cancer	6.58e-06	4.89e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NCOA3—prostate cancer	6.53e-06	4.86e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NCOA3—prostate cancer	6.47e-06	4.81e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SULT2A1—prostate cancer	6.41e-06	4.76e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NOS3—prostate cancer	6.35e-06	4.72e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MED12—prostate cancer	6.31e-06	4.69e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CD—prostate cancer	6.28e-06	4.67e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GNG5—prostate cancer	6.26e-06	4.65e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HPGDS—prostate cancer	6.23e-06	4.63e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2C19—prostate cancer	6.19e-06	4.6e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKT1—prostate cancer	6.17e-06	4.58e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HPGDS—prostate cancer	6.17e-06	4.58e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTEN—prostate cancer	6.15e-06	4.57e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2C19—prostate cancer	6.13e-06	4.56e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTT1—prostate cancer	6.05e-06	4.49e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ACHE—prostate cancer	6.05e-06	4.49e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NCOA3—prostate cancer	6.03e-06	4.48e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTT1—prostate cancer	5.98e-06	4.45e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ACHE—prostate cancer	5.98e-06	4.45e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2A6—prostate cancer	5.98e-06	4.44e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—NOS3—prostate cancer	5.93e-06	4.41e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2A6—prostate cancer	5.91e-06	4.4e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AKT1—prostate cancer	5.9e-06	4.38e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—EP300—prostate cancer	5.86e-06	4.36e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CB—prostate cancer	5.86e-06	4.35e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKR1C3—prostate cancer	5.81e-06	4.32e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGS2—prostate cancer	5.8e-06	4.31e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PRKACB—prostate cancer	5.78e-06	4.3e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKR1C3—prostate cancer	5.75e-06	4.28e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HPGDS—prostate cancer	5.75e-06	4.27e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PRKACB—prostate cancer	5.72e-06	4.25e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP17A1—prostate cancer	5.72e-06	4.25e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2C19—prostate cancer	5.71e-06	4.25e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP17A1—prostate cancer	5.66e-06	4.21e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.66e-06	4.21e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.6e-06	4.16e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTT1—prostate cancer	5.58e-06	4.14e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ACHE—prostate cancer	5.58e-06	4.14e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2A6—prostate cancer	5.51e-06	4.1e-05	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—prostate cancer	5.5e-06	4.09e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CB—prostate cancer	5.47e-06	4.07e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NCOA2—prostate cancer	5.45e-06	4.05e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGS2—prostate cancer	5.42e-06	4.03e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NCOA2—prostate cancer	5.4e-06	4.01e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKR1C3—prostate cancer	5.36e-06	3.99e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PRKACB—prostate cancer	5.33e-06	3.96e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP17A1—prostate cancer	5.28e-06	3.92e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.22e-06	3.88e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC5A5—prostate cancer	5.2e-06	3.87e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC5A5—prostate cancer	5.15e-06	3.83e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2E1—prostate cancer	5.08e-06	3.78e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTEN—prostate cancer	5.06e-06	3.76e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NCOA2—prostate cancer	5.03e-06	3.74e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2E1—prostate cancer	5.03e-06	3.74e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NQO1—prostate cancer	5.02e-06	3.73e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NQO1—prostate cancer	4.97e-06	3.7e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TH—prostate cancer	4.95e-06	3.68e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TH—prostate cancer	4.9e-06	3.64e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP3A4—prostate cancer	4.9e-06	3.64e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP3A4—prostate cancer	4.85e-06	3.6e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—EP300—prostate cancer	4.83e-06	3.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP1B1—prostate cancer	4.82e-06	3.58e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC5A5—prostate cancer	4.8e-06	3.57e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP1B1—prostate cancer	4.77e-06	3.54e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTEN—prostate cancer	4.73e-06	3.52e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2E1—prostate cancer	4.69e-06	3.48e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GGT1—prostate cancer	4.67e-06	3.47e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NQO1—prostate cancer	4.63e-06	3.44e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GGT1—prostate cancer	4.62e-06	3.43e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NCOA1—prostate cancer	4.6e-06	3.42e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TH—prostate cancer	4.57e-06	3.39e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NCOA1—prostate cancer	4.55e-06	3.38e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP19A1—prostate cancer	4.53e-06	3.37e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP3A4—prostate cancer	4.52e-06	3.36e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—EP300—prostate cancer	4.51e-06	3.35e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP19A1—prostate cancer	4.48e-06	3.33e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP1B1—prostate cancer	4.44e-06	3.3e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—RXRA—prostate cancer	4.37e-06	3.25e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3CA—prostate cancer	4.34e-06	3.22e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—RXRA—prostate cancer	4.33e-06	3.21e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GGT1—prostate cancer	4.3e-06	3.2e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NCOA1—prostate cancer	4.24e-06	3.15e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—COMT—prostate cancer	4.21e-06	3.13e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTP1—prostate cancer	4.19e-06	3.11e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP19A1—prostate cancer	4.18e-06	3.1e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—COMT—prostate cancer	4.17e-06	3.1e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTP1—prostate cancer	4.15e-06	3.08e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ITPR1—prostate cancer	4.12e-06	3.06e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ITPR1—prostate cancer	4.08e-06	3.03e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—RXRA—prostate cancer	4.03e-06	3e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TYMS—prostate cancer	3.9e-06	2.9e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—COMT—prostate cancer	3.88e-06	2.89e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTP1—prostate cancer	3.87e-06	2.87e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TYMS—prostate cancer	3.86e-06	2.87e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTM1—prostate cancer	3.85e-06	2.86e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTM1—prostate cancer	3.81e-06	2.83e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ITPR1—prostate cancer	3.8e-06	2.83e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LPL—prostate cancer	3.78e-06	2.81e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LPL—prostate cancer	3.74e-06	2.78e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP1A1—prostate cancer	3.65e-06	2.71e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ERCC2—prostate cancer	3.62e-06	2.69e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP1A1—prostate cancer	3.61e-06	2.68e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TYMS—prostate cancer	3.59e-06	2.67e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ERCC2—prostate cancer	3.58e-06	2.66e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3CA—prostate cancer	3.57e-06	2.65e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTM1—prostate cancer	3.55e-06	2.64e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKT1—prostate cancer	3.54e-06	2.63e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LPL—prostate cancer	3.49e-06	2.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTHFR—prostate cancer	3.4e-06	2.53e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTHFR—prostate cancer	3.37e-06	2.5e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP1A1—prostate cancer	3.37e-06	2.5e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ERCC2—prostate cancer	3.34e-06	2.48e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARA—prostate cancer	3.34e-06	2.48e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3CA—prostate cancer	3.34e-06	2.48e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARA—prostate cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTHFR—prostate cancer	3.14e-06	2.33e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CAV1—prostate cancer	3.14e-06	2.33e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CAV1—prostate cancer	3.11e-06	2.31e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARA—prostate cancer	3.08e-06	2.29e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKT1—prostate cancer	2.92e-06	2.17e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CAV1—prostate cancer	2.9e-06	2.15e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CG—prostate cancer	2.86e-06	2.12e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CG—prostate cancer	2.83e-06	2.1e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKT1—prostate cancer	2.73e-06	2.03e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—INS—prostate cancer	2.71e-06	2.01e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—INS—prostate cancer	2.68e-06	1.99e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CREBBP—prostate cancer	2.65e-06	1.97e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CG—prostate cancer	2.64e-06	1.96e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CREBBP—prostate cancer	2.62e-06	1.95e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CD—prostate cancer	2.51e-06	1.87e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—INS—prostate cancer	2.5e-06	1.86e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CD—prostate cancer	2.49e-06	1.85e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CREBBP—prostate cancer	2.45e-06	1.82e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NOS3—prostate cancer	2.37e-06	1.76e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NOS3—prostate cancer	2.35e-06	1.75e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CD—prostate cancer	2.32e-06	1.72e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CB—prostate cancer	2.19e-06	1.63e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NOS3—prostate cancer	2.19e-06	1.63e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGS2—prostate cancer	2.17e-06	1.61e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CB—prostate cancer	2.17e-06	1.61e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGS2—prostate cancer	2.15e-06	1.6e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CB—prostate cancer	2.02e-06	1.5e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGS2—prostate cancer	2e-06	1.49e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTEN—prostate cancer	1.89e-06	1.41e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTEN—prostate cancer	1.87e-06	1.39e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—EP300—prostate cancer	1.81e-06	1.34e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—EP300—prostate cancer	1.79e-06	1.33e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTEN—prostate cancer	1.75e-06	1.3e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—EP300—prostate cancer	1.67e-06	1.24e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3CA—prostate cancer	1.34e-06	9.93e-06	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3CA—prostate cancer	1.32e-06	9.82e-06	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3CA—prostate cancer	1.23e-06	9.16e-06	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKT1—prostate cancer	1.09e-06	8.11e-06	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKT1—prostate cancer	1.08e-06	8.02e-06	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKT1—prostate cancer	1.01e-06	7.48e-06	CbGpPWpGaD
